NASTAD’S 2022 National HIV & Hepatitis Technical Assistance Meeting

Published On: October 6, 2022By Categories: Company News/Press/Partnerships

Share:

NASTAD’S 2022 National HIV & Hepatitis Technical Assistance Meeting

“NASTAD’s 2022 National HIV and Hepatitis Technical Assistance Meeting will be held on October 11-14, 2022 in Washington, D.C.  The NASTAD’s 2022 National HIV & Hepatitis Technical Assistance Meeting will allow ADAP coordinators, Ryan White HIV/AIDS Program (RWHAP) Part B coordinators, prevention managers, and hepatitis coordinators from states and CDC directly-funded jurisdictions to participate in various conversations about HIV and hepatitis policy, clinical developments, and innovative programming. The theme is “Responding to Shifting Public Health Challenges,” and will focus on health department efforts to address a confluence of challenges including COVID-19, MPV, reproductive health, and the politicization of public health work. The meeting, which will take place in person and include a virtual participation option, is formatted to include plenary sessions, breakout discussion sessions, and affinity sessions; more than 500 participants are expected during the course of the three-day event.”

Molecular Testing Labs is a Proud Sponsor

Molecular Testing Labs is a proud sponsor for NASTAD’s 2022 National HIV & Hepatitis Technical Assistance Meeting. During this three-day event Molecular Testing Lab’s very own Chief Commercial Officer, James York, and Director of Business Development – Public Health, Chip House will be in D.C. Empowering Lives On a Molecular Level. Interested in connecting? Complete the form, so that we can arrange a time to chat.

To download the event app visit: https://nastad.org/app

Additional HIV & Hepatitis Resources

The Ryan White HIV/AIDS Program (RWHAP) helps low-income people with HIV. We help them receive: Medical care , Medications , and Essential support services to help them stay in care. More than 50% of people with diagnosed HIV – about a half million people – receive services through the RWHAP each year.  We also help diagnose, treat, prevent, and respond to end the HIV epidemic in the U.S.

The Hep B Community is a global peer-led, volunteer-driven forum to support those living with and affected by hep B. We are dedicated to connecting people affected by hep B with each other and with verified experts in the field, who provide trustworthy and accurate advice.

The Global Fund works in partnership with governments, civil society, technical agencies, the private sector, and people affected by diseases to challenge barriers and embrace innovation. Since the peak of the HIV crisis in the late 1990s and early 2000s, The Global Fund has cut annual AIDS-related deaths and new infections by half. Of the 38 million people living with HIV, 27.5 million are on antiretroviral therapy today—21.9 million in the countries where the Global Fund invests.

A national nonprofit dedicated to finding a cure and improving the quality of life for people affected by hepatitis B worldwide. The Hepatitis B Foundation has a dedicated research institute, a Hepatitis Delta Connect Program, and a storytelling campaign that is sweeping the community!

 

About the Author: Staff

MTL
Molecular Testing Labs is headquartered in Vancouver, Washington. Molecular’s leaders are visionary in their approach to precision laboratory diagnostics and are committed to revolutionizing accessibility to testing via proprietary technology systems, advanced logistics, and cutting-edge research and development. They provide laboratory solutions through collaborative partnerships with payors, private healthcare institutions, universities, commercial partners, and public health organizations. Molecular Testing Labs is a CLIA- and CAP-accredited, state-of-the-art reference laboratory that is passionate about bridging the gap and building bonds between the large communities that have access to diagnostics and the smaller underserved communities that deserve that same access. Molecular Testing Labs is pioneering distribution and specimen collection methods that open access to medical testing where geographic, financial, and stigma barriers create gaps in the delivery of healthcare.